The nucleotide sequence of the gene encoding a novel cephalosporinase (LAT-1), carried by a non-selftransferable plasmid from Kiebsiella pneumoniae, has been determined. It was found that the sequence shares a high degree of homology with the Citrobacterfreundii OS60 ampC structural gene.
Possession of plasmid-mediated extended-spectrum derivatives of TEM-1/2 or SHV-1 ,B-lactamases is the main cause of resistance of Kiebsiella pneumoniae to broad-spectrum cephalosporins (9) . These enzymes are ineffective against cephamycins and subject to strong inhibition by clavulanate and sulbactam. However, there have been studies describing novel plasmid-mediated ,B-lactamases which resemble the chromosomal cephalosporinases in that they confer resistance to virtually all cephalosporins, including cephamycins, and are not inhibited by the P-lactamase "suicide" inhibitors (1-4, 7, 8, 14) . In a previous study, we reported the identification of such a P-lactamase, designated LAT-1 (14) . The enzyme was encoded by a small non-self-transferable plasmid found in a K pneumoniae clinical strain resistant to cephalosporins and P-lactam-inhibitor combinations. Subsequent hydrolytic and inhibition studies showed that the enzyme displayed characteristics of a chromosomal cephalosporinase. In the present work, the nucleotide sequence of the corresponding gene has been determined.
Escherichia coli XL1-Blue (Stratagene, La Jolla, Calif.), E. coli DH5a, and a Citrobacterfreundii clinical isolate producing constitutively large amounts of chromosomal cephalosporinase were utilized. The 8.5-kbp wild-type plasmid pHPI5 coding for LAT-1 (14) and the phagemid pBC SK(+) (Stratagene) were used. Restriction enzymes were obtained from New England Biolabs (Beverly, Mass.). DNA fragments were recovered from low-melting-point agarose by standard protocols (10) . Nucleotide sequencing of double-stranded plasmid DNA was performed by the dideoxy chain termination method (11) with ct-35S-dATP and the Sequenase version 2.1 kit (U.S. Biochemical Corp., Cleveland, Ohio), using KS, SK, M13, and M13 reverse primers (Stratagene). Oligonucleotide primers prepared in an Applied Biosystems (Foster City, Calif.) DNA synthesizer according to the instructions of the manufacturer were also used. Antibiotic susceptibility to P-lactams was assessed by a microdilution technique and standard antibiograms. Isoelectric focusing of ,B-lactamases was performed on polyacrylamide gels containing ampholytes, and the enzymes were visualized with nitrocefin. Hydrolytic studies using cephaloridine, cephalothin, and nitrocefin as substrates were performed as described previously (14) . sequences and proteins were carried out by using the EMBL database.
The recombinant plasmid pBL19 was constructed by cloning a 2.5-kbp BamHI fragment of plasmid pHPI5 into pBC SK(+). The corresponding gene was further localized in a 1.7-kbp BamHI-EcoRI fragment, which was cloned into pBC SK(+), and the resulting plasmid was designated pBL23. It was found that E. coli strains harboring pBL23 were resistant to ampicillin (MIC > 128 ,ug/ml), cefotaxime (MIC = 128 ,ug/ml), ceftazidime (MIC > 64 ,ug/ml), cefoxitin (MIC = 64 ,ug/ml), and amoxicillin-clavulanate combination (MICs of >64 and >32 jig/ml). Isoelectric focusing showed that pBL23 coded for the LAT-1 enzyme. Several overlapping fragments derived from the 1.7-kbp insert were subcloned into the same vector, and the respective sequences of both DNA strands were determined. Figure 1 shows the nucleotide sequence of the blaLAT-l gene.
An ATG codon at position 142 initiates a long open reading frame of 1,142 nucleotides which terminates at position 1285 with a TAA codon. A potential Shine-Dalgarno ribosomebinding sequence, AcGGAacT, is found six bases before the ATG codon. After a search for homologies with other known P-lactamase genes, it was found that the determined sequence shares a high degree of homology with the enterobacterial chromosomal cephalosporinases. The closest match was obtai-ned with the C. freundii OS60 ampC gene (5) . Interestingly, in addition to the similarity between the structural genes, the region between nucleotides 32 and 142 was identical to a part of the ampR-ampC intercistronic region of C. freundii including 15 bases of the AmpR protected region (6) . With the aid of the latter sequence, we localized the possible -10 (CACACT) and -35 (TTGTCA) regions of the promoter of the blaLAT-l gene (Fig. 1) .
The deduced amino acid sequence of LAT-1 is shown in Fig.  2 . The 1-lactamase precursor consists of 381 amino acids and has an estimated molecular weight of 42,005. Comparison of LAT-1 with the AmpC precursor of C. freundii OS60 (CFAMPC) showed that, in the two equal-length enzymes, 363 amino acids in each enzyme were identical and 3 could be characterized as similar (95.3% identity and 96.1% similarity). On the basis of this similarity and from hydropathy plots, it is assumed that the signal peptide consists of the initial 20 amino acid residues. The estimated molecular weight of the mature enzyme is 39,857. The high degree of similarity between LAT-1 and CFAMPC also includes signal peptides in which 19 of 20 amino acids occupy identical positions. Overall, the mature LAT-1 1-lactamase differs in 17 amino acids. In previous studies with the cephalosporinase of the C. freundii GN346 strain, it was found that Ser-64, Lys-67, Lys-315, and Gly-317 are important for the expression of catalytic activity (12, 13, ANTIMICROB. AGENTS CHEMOTHER. 
